Security
Chemomab Therapeutics Ltd. American Depositary Share · CMMB
CMMBNASDAQotherCurrentCIK 1534248Updated Nov 3, 2026
Name history
Anchiano Therapeutics Ltd. · through Mar 17, 2021BioCancell Ltd. · through Nov 3, 2015
CMMB price & chart
Loading TradingView…
NASDAQ:CMMB on TradingView ↗In the news
No coverage from other publishers is available.
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2022 | Q3 2021 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 50,219,000Source | 67,440,000Source | 11,129,000Source | 14,544,000Source | 28,849,000Source | 56,378,000Source | 35,013,000Source | 60,956,000Source | 13,812,000Source | 16,964,000Source | 22,151,000Source | 43,063,000Source |
| Property, Plant and Equipment, NetUSD | 380,000Source | 234,000Source | 217,000Source | 276,000Source | 338,000Source | 355,000Source | 352,000Source | 358,000Source | 176,000Source | 250,000Source | 303,000Source | 367,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 10,741,000Source | 37,744,000Source | 5,448,000Source | 5,036,000Source | 10,382,000Source | 9,883,000Source | 20,765,000Source | 13,827,000Source | 7,564,000Source | 6,071,000Source | 9,292,000Source | 13,519,000Source |
| Assets, CurrentUSD | 48,725,000Source | 65,842,000Source | 10,614,000Source | 13,455,000Source | 27,705,000Source | 54,830,000Source | 33,778,000Source | 59,340,000Source | 13,425,000Source | 16,040,000Source | 20,897,000Source | 41,736,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,259,000Source | 1,574,000Source | 1,101,000Source | 654,000Source | 1,042,000Source | 3,106,000Source | 995,000Source | 1,934,000Source | 3,059,000Source | 1,698,000Source | 1,037,000Source | 1,766,000Source |
| Operating Lease, Right-of-Use AssetUSD | 261,000Source | 359,000Source | 0Source | 341,000Source | 160,000Source | 295,000Source | 193,000Source | 309,000Source | 0Source | 289,000Source | 392,000Source | 227,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 5,595,000Source | 1,928,000Source | 1,430,000Source | 4,559,000Source | 6,858,000Source | 4,542,000Source | 7,059,000Source | 3,720,000Source | 1,478,000Source | 3,427,000Source | 5,154,000Source | 6,840,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 100,171,000Source | 96,649,000Source | 117,702,000Source | 106,162,000Source | 103,751,000Source | 99,303,000Source | 101,744,000Source | 98,513,000Source | 123,952,000Source | 116,160,000Source | 105,675,000Source | 101,260,000Source |
| Retained Earnings (Accumulated Deficit)USD | -55,547,000Source | -31,137,000Source | -108,003,000Source | -96,177,000Source | -80,542,000Source | -47,467,000Source | -72,572,000Source | -41,277,000Source | -111,618,000Source | -102,623,000Source | -88,678,000Source | -63,819,000Source |
| Stockholders' Equity Attributable to ParentUSD | 44,624,000Source | 65,512,000Source | 9,699,000Source | 9,985,000Source | 21,991,000Source | 51,836,000Source | 27,954,000Source | 57,236,000Source | 12,334,000Source | 13,537,000Source | 16,997,000Source | 36,223,000Source |
| Liabilities and EquityUSD | 50,219,000Source | 67,440,000Source | 11,129,000Source | 14,544,000Source | 28,849,000Source | 56,378,000Source | 35,013,000Source | 60,956,000Source | 13,812,000Source | 16,964,000Source | 22,151,000Source | 43,063,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 5,477,000Source | 1,630,000Source | 1,430,000Source | 4,308,000Source | 6,825,000Source | 4,394,000Source | 6,997,000Source | 3,517,000Source | 1,478,000Source | 3,218,000Source | 4,838,000Source | 6,749,000Source |
| Operating Lease, Liability, CurrentUSD | 126,000Source | 61,000Source | 0Source | 109,000Source | 108,000Source | 132,000Source | 115,000Source | 116,000Source | 0Source | 115,000Source | 76,000Source | 123,000Source |
| Operating Lease, Liability, NoncurrentUSD | 118,000Source | 298,000Source | 0Source | 251,000Source | 33,000Source | 148,000Source | 62,000Source | 203,000Source | 0Source | 209,000Source | 316,000Source | 91,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 2,577,000Source | 637,000Source | 666,000Source | 2,546,000Source | 2,503,000Source | 1,712,000Source | 3,164,000Source | 1,248,000Source | 337,000Source | 1,563,000Source | 3,423,000Source | 3,378,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 9,500,000Source | — | — | — | — | — | 10,400,000Source | 14,300,000Source | — | — |
cash flow · annual statements
| Line item | Q4 2022 | Q3 2022 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -8,753,000Source | -5,104,000Source | -8,995,000Source | -13,945,000Source | -24,221,000Source | -27,646,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 484,000Source | 874,000Source | 623,000Source | 617,000Source | 1,491,000Source | 3,211,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -7,186,000Source | -3,711,000Source | -11,130,000Source | -15,386,000Source | -23,611,000Source | -20,370,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 14,432,000Source | 2,382,000Source | 5,390,000Source | 2,297,000Source | 15,879,000Source | 19,533,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 1,000Source | 14,000Source | 3,000Source | 0Source | 3,000Source | 68,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 0Source | 0Source | 7,157,000Source | 9,868,000Source | 3,504,000Source | -808,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 7,246,000Source | -1,329,000Source | 1,417,000Source | -3,221,000Source | -4,228,000Source | -1,645,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 10,818,000Source | 5,596,000Source | 5,110,000Source | 10,456,000Source | 9,960,000Source | 20,842,000Source | 13,912,000Source | 7,564,000Source | 6,147,000Source | 9,368,000Source | 13,596,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 5,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | 623,000Source | 617,000Source | 1,491,000Source | 3,211,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 9,500,000Source | — | — | — | — | — | 10,400,000Source | 14,300,000Source | — | — |
| DepreciationUSD | — | — | — | — | — | — | 16,000Source | 13,000Source | 70,000Source | 53,000Source | 67,000Source | 58,000Source |
| General and Administrative ExpenseUSD | — | 2,894,000Source | — | 840,000Source | 3,175,000Source | 3,340,000Source | 2,162,000Source | 2,575,000Source | 3,734,000Source | 3,412,000Source | 7,078,000Source | 11,556,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | — | 0Source | 34,000Source | -544,000Source | 21,000Source | 0Source | 0Source | 0Source | 0Source | -534,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | -8,080,000Source | -2,057,000Source | -3,631,000Source | -7,970,000Source | -6,190,000Source | -8,753,000Source | -5,104,000Source | -8,995,000Source | -13,945,000Source | -24,221,000Source | -27,646,000Source |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | 572,000Source | 794,000Source | 1,238,000Source | 353,000Source |
| Operating ExpensesUSD | — | 8,317,000Source | — | 3,768,000Source | 8,195,000Source | 6,254,000Source | 9,049,000Source | 5,320,000Source | 9,567,000Source | 14,739,000Source | 25,459,000Source | 28,533,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | 392,000Source | 17,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | 12,000Source | 0Source | 0Source | 143,000Source |
income statement · annual statements
| Line item | Q4 2022 | Q3 2022 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — | — | — | — | — | — | —Source | —Source | —Source | — |
| Operating Income (Loss)USD | — | — | — | — | — | — | — | — | -112,000,000Source | -103,000,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | -8,080,000Source | — | -3,631,000Source | -7,936,000Source | -6,734,000Source | -8,732,000Source | -5,104,000Source | -8,995,000Source | -13,945,000Source | -24,221,000Source | -28,180,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | — | 0Source | 34,000Source | -544,000Source | 21,000Source | 0Source | 0Source | 0Source | 0Source | -534,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | -8,080,000Source | -2,057,000Source | -3,631,000Source | -7,970,000Source | -6,190,000Source | -8,753,000Source | -5,104,000Source | -8,995,000Source | -13,945,000Source | -24,221,000Source | -27,646,000Source |
| Earnings Per Share, BasicUSD per share | — | 0.04Source | — | 0.01Source | 0.04Source | 0.03Source | 0.04Source | 0.02Source | 0.02Source | 0.04Source | 0.1Source | 0.12Source |
| Earnings Per Share, DilutedUSD per share | — | 0.04Source | — | 0.01Source | 0.04Source | 0.03Source | 0.04Source | 0.02Source | 0.02Source | 0.04Source | 0.1Source | 0.12Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | 228,773,418Source | — | 286,080,133Source | 221,674,130Source | 228,173,276Source | 220,996,240Source | 228,090,300Source | 510,227,715Source | 359,048,638Source | 234,998,859Source | 227,589,288Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | 228,773,418Source | — | 286,080,133Source | 221,674,130Source | 228,173,276Source | 220,996,240Source | 228,090,300Source | 510,227,715Source | 359,048,638Source | 234,998,859Source | 227,589,288Source |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | 2,894,000Source | — | 840,000Source | 3,175,000Source | 3,340,000Source | 2,162,000Source | 2,575,000Source | 3,734,000Source | 3,412,000Source | 7,078,000Source | 11,556,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 9,035,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | — | — | — | — | — | — | 0.02Source | 0.04Source | 0.1Source | 0.12Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | — | — | — | — | — | — | 0.02Source | 0.04Source | 0.1Source | 0.12Source |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | 572,000Source | 794,000Source | 1,238,000Source | 353,000Source |
| Operating ExpensesUSD | — | 8,317,000Source | — | 3,768,000Source | 8,195,000Source | 6,254,000Source | 9,049,000Source | 5,320,000Source | 9,567,000Source | 14,739,000Source | 25,459,000Source | 28,533,000Source |
| Other General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | 142,000Source | 124,000Source | 323,000Source | 1,423,000Source |
| Research and Development ExpenseUSD | — | 5,423,000Source | — | 2,928,000Source | 5,020,000Source | 2,914,000Source | 6,887,000Source | 2,745,000Source | 5,833,000Source | 11,327,000Source | 18,381,000Source | 16,977,000Source |